Two kinds of brain radiation compared for lung cancer that spread to the brain
Original title: SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a large, late stage trial, but it is still a test.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This trial compares a focused kind of brain radiation with whole-brain radiation: Radiation given to the whole brain, rather than aimed at one spot. It is used when there are too many tumors to aim at one at a time. See the glossary that tries to protect memory.
Who this trial is for. This is for people with no more than 10 brain tumors from small cell lung cancer. It compares focused radiation with whole-brain radiation: Radiation given to the whole brain, rather than aimed at one spot. It is used when there are too many tumors to aim at one at a time. See the glossary that avoids the hippocampus, the memory zone of the brain.
Where it stands. This trial has not reported results. It is measuring the effect of each kind of radiation on these brain tumors. The answer is not in yet.
What this means, and what it doesn't
What it could mean: Someone who fits this picture could ask their care team about this trial. The team can say if it makes sense for them. It is one way to try care that is still being studied.
What it doesn't mean: This does not mean one kind of radiation is proven better than the other. A trial is a test, not a treatment that is known to work. Being in a trial is not a guarantee that it will help. It is not a promise of a cure.
Source: ClinicalTrials.gov, October 8, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.